Catalyst Wire Dossier Catalyst Wire Dossier

Arepanrix

Influenza vaccine (H1N1) · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Arepanrix, covering 2011-10-25 to 2017-12-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older [Phase 4]

See pricing